0001209191-13-022280.txt : 20130423
0001209191-13-022280.hdr.sgml : 20130423
20130423163055
ACCESSION NUMBER: 0001209191-13-022280
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130419
FILED AS OF DATE: 20130423
DATE AS OF CHANGE: 20130423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 13776835
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-04-19
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
EVP & CFO
Common Stock
2013-04-19
4
M
0
15858
51.75
A
46068
D
Common Stock
2013-04-19
4
M
0
27187
38.80
A
73255
D
Common Stock
2013-04-19
4
M
0
24921
33.82
A
98176
D
Common Stock
2013-04-19
4
M
0
40781
39.05
A
138957
D
Common Stock
2013-04-19
4
M
0
54375
33.55
A
193332
D
Common Stock
2013-04-19
4
M
0
33983
33.28
A
227315
D
Common Stock
2013-04-19
4
M
0
36250
35.35
A
263565
D
Common Stock
2013-04-19
4
M
0
54375
36.30
A
317940
D
Common Stock
2013-04-19
4
M
0
28570
28.84
A
346510
D
Common Stock
2013-04-19
4
M
0
36250
32.16
A
382760
D
Common Stock
2013-04-19
4
M
0
73500
35.64
A
456260
D
Common Stock
2013-04-19
4
M
0
300000
33.00
A
756260
D
Common Stock
2013-04-19
4
M
0
13593
37.86
A
769853
D
Common Stock
2013-04-19
4
S
0
691318
81.50
D
78535
D
Common Stock
2013-04-19
4
S
0
54367
85.00
D
24168
D
Common Stock
5205
I
401(k)
Employee Stock Option (right to buy)
35.64
2013-04-19
4
M
0
73500
0.00
D
2016-02-01
Common Stock
73500
0
D
Employee Stock Option (right to buy)
35.35
2013-04-19
4
M
0
36250
0.00
D
2016-07-19
Common Stock
36250
0
D
Employee Stock Option (right to buy)
36.30
2013-04-19
4
M
0
54375
0.00
D
2017-01-23
Common Stock
54375
0
D
Employee Stock Option (right to buy)
28.84
2013-04-19
4
M
0
28570
0.00
D
2017-07-11
Common Stock
28570
0
D
Employee Stock Option (right to buy)
32.16
2013-04-19
4
M
0
36250
0.00
D
2018-07-23
Common Stock
36250
0
D
Employee Stock Option (right to buy)
33.55
2013-04-19
4
M
0
54375
0.00
D
2019-02-04
Common Stock
54375
0
D
Employee Stock Option (right to buy)
33.28
2013-04-19
4
M
0
33983
0.00
D
2019-07-15
Common Stock
33983
2267
D
Employee Stock Option (right to buy)
33.00
2013-04-19
4
M
0
300000
0.00
D
2019-10-21
Common Stock
300000
0
D
Employee Stock Option (right to buy
39.05
2013-04-19
4
M
0
40781
0.00
D
2020-02-03
Common Stock
40781
13594
D
Employee Stock Option (right to buy)
33.82
2013-04-19
4
M
0
24921
0.00
D
2020-07-13
Common Stock
24921
11329
D
Employee Stock Option (right to buy)
38.80
2013-04-19
4
M
0
27187
0.00
D
2021-02-02
Common Stock
27187
27188
D
Employee Stock Option (right to buy)
51.75
2013-04-19
4
M
0
15858
0.00
D
2021-07-12
Common Stock
15858
20392
D
Employee Stock Option (right to buy)
37.86
2013-04-19
4
M
0
13593
0.00
D
2022-02-01
Common Stock
13593
40782
D
Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
Fully vested.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/16/2009.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/04/2010.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/14/2010.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/03/2011.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/02/2012.
Kenneth L. Horton, Attorney-In-Fact
2013-04-23